MDMAPharmala Biotech HoldingsMDMA info
$0.17info4.17%24h
Global rank28920
Market cap$14.66M
Change 7d-16.67%
YTD Performance-
SP500 benchmark
P/E-17.34
P/S39.72
Revenue$369.01K
Earnings-$540.90K
Dividend yield-
Main Sector
Healthcare

Pharmala Biotech Holdings (MDMA) Net Assets

MDMA Net Assets in 2024: $1.38M

As of 17 Jan 2025, Pharmala Biotech Holdings net assets is $1.38M, an decrease of -27.42% to 2023. Net assets are calculated as total assets minus total liabilities. This value represents the Pharmala Biotech Holdings overall net worth, providing an insight into company's financial health and stability. Net assets are a key indicator of a stock value, reflecting what it essentially owns minus what it owes.

Pharmala Biotech Holdings Net Assets History from 2021 to 2025

-
Value:-

MDMA Net Assets History by year

YearNet assetsChange
2023$1.38M-27.42%
2022$1.91M-28.21%
2021$2.66M-

View the Top Net Assets Companies

logo
Facebook Icon
Twitter Icon
Linkedin Icon
© 2025 Topstocks.org